Early intervention key to mitigate neurocognitive effects of pediatric cancer treatment

HemOnc Today - September 21, 2021

"Estimates have shown that approximately one-third of all cancer survivors and approximately 40% or more of brain tumor survivors experience neurocognitive impairment brought on by both the disease and its treatments.... Karin S. Walsh, PsyD, pediatric neuropsychologist in the division of pediatric neuropsychology at Children's National Hospital: 'Younger children, especially those diagnosed at an age younger than 5 years, are a higher risk group.' " Read Article >>